Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Cytokine
|
April 9, 2011
PCA-ELISA: a sensitive method to quantify free and masked forms of HMGB1
Stéphanie Barnay-Verdier, Claire Gaillard, Mélanie Messmer, et al.
Intensive Care Medicine
|
March 2, 2011
Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock
Stéphanie Barnay-Verdier, Lakhdar Fattoum, Chloé Borde, et al.
Plos One
|
February 2, 2011
Stepwise release of biologically active HMGB1 during HSV-2 infection
Chloé Borde, Stéphanie Barnay-Verdier, Claire Gaillard, et al.
AIDS (London, England)
|
January 27, 2007
High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells
Sylvain Thierry, Joël Gozlan, Amandine Jaulmes, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 30, 2024
High-Resolution Molecular-Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2)
Quentin Delobelle, Théo Jaffrelot Inizan, Olivier Adjoua, et al.
Biochimie
|
November 20, 2012
DsRed-mediated oligomerization stabilizes HMGB1 on chromatin in vivo and on DNA in vitro
Mélanie Messmer, Christophe Klein, Rachel Boniface, et al.
Blood
|
December 8, 2009
High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription
Benoît Laurent, Voahangy Randrianarison-Huetz, Vincent Maréchal, et al.
Cellular Immunology
|
November 27, 2019
Emergence of antibodies endowed with proteolytic activity against High-mobility group box 1 protein (HMGB1) in patients surviving septic shock
Stéphanie Barnay-Verdier, Chloé Borde, Lakhdar Fattoum, et al.
Protein Expression and Purification
|
May 31, 2019
Detection of IgG directed against a recombinant form of Epstein-Barr virus BALF0/1 protein in patients with nasopharyngeal carcinoma
Zhouwulin Shao, Chloé Borde, Christophe H Marchand, et al.
Antiviral Research
|
October 4, 2019
Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation
Marcos P Thomé, Chloé Borde, Annette K Larsen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Cytokine
|
April 9, 2011
PCA-ELISA: a sensitive method to quantify free and masked forms of HMGB1
Stéphanie Barnay-Verdier, Claire Gaillard, Mélanie Messmer, et al.
Intensive Care Medicine
|
March 2, 2011
Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock
Stéphanie Barnay-Verdier, Lakhdar Fattoum, Chloé Borde, et al.
Plos One
|
February 2, 2011
Stepwise release of biologically active HMGB1 during HSV-2 infection
Chloé Borde, Stéphanie Barnay-Verdier, Claire Gaillard, et al.
AIDS (London, England)
|
January 27, 2007
High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells
Sylvain Thierry, Joël Gozlan, Amandine Jaulmes, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 30, 2024
High-Resolution Molecular-Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2)
Quentin Delobelle, Théo Jaffrelot Inizan, Olivier Adjoua, et al.
Biochimie
|
November 20, 2012
DsRed-mediated oligomerization stabilizes HMGB1 on chromatin in vivo and on DNA in vitro
Mélanie Messmer, Christophe Klein, Rachel Boniface, et al.
Blood
|
December 8, 2009
High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription
Benoît Laurent, Voahangy Randrianarison-Huetz, Vincent Maréchal, et al.
Cellular Immunology
|
November 27, 2019
Emergence of antibodies endowed with proteolytic activity against High-mobility group box 1 protein (HMGB1) in patients surviving septic shock
Stéphanie Barnay-Verdier, Chloé Borde, Lakhdar Fattoum, et al.
Protein Expression and Purification
|
May 31, 2019
Detection of IgG directed against a recombinant form of Epstein-Barr virus BALF0/1 protein in patients with nasopharyngeal carcinoma
Zhouwulin Shao, Chloé Borde, Christophe H Marchand, et al.
Antiviral Research
|
October 4, 2019
Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation
Marcos P Thomé, Chloé Borde, Annette K Larsen, et al.
Page
of 4